Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. 더 보기
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its fourth quarter and full year 2024...
Approval of three important therapies for dementia, oncology and gastrointestinal disease Granted 180-day exclusivity for memantine/donepezil extended-release capsules Tentative approval of...
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.13 | 1.50987224158 | 8.61 | 8.88 | 8.375 | 824925 | 8.69638063 | CS |
4 | 0.7696 | 9.65572618689 | 7.9704 | 8.88 | 7.625 | 1111307 | 8.18933059 | CS |
12 | 0.36 | 4.29594272076 | 8.38 | 9.475 | 7.52 | 1160960 | 8.32389643 | CS |
26 | 1.3 | 17.4731182796 | 7.44 | 9.475 | 6.5 | 1170538 | 8.2537004 | CS |
52 | 3.1 | 54.9645390071 | 5.64 | 9.475 | 5.01 | 1339392 | 7.09522356 | CS |
156 | 2.86 | 48.6394557823 | 5.88 | 9.475 | 5.01 | 1344058 | 6.97943481 | CS |
260 | 2.86 | 48.6394557823 | 5.88 | 9.475 | 5.01 | 1344058 | 6.97943481 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관